IRF1 |
K562 (myelogenous leukemia) |
Interferon gamma treatment - 30 minutes (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EGK
|
MA0050.2
|
IRF1 |
K562 (myelogenous leukemia) |
Interferon alpha treatment - 6 hours (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EGL
|
MA0050.2
|
IRF1 |
K562 (myelogenous leukemia) |
Interferon gamma treatment - 6 hours (Snyder) |
Permissive
|
Homo sapiens |
ENCSR000EGT
|
MA0050.2
|
IRF1 |
K562 (myelogenous leukemia) |
30 m of Interferon alpha (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EGU
|
MA0050.2
|
IRF1 |
dendritic cells |
LPS, 0 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0050.2
|
IRF1 |
dendritic cells |
LPS, 120 min |
Permissive
Robust
|
Mus musculus |
GSE36099
...
|
MA0050.2
|
IRF1 |
dendritic cells |
LPS, 30 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0050.2
|
IRF1 |
BMDM (bone marrow-derived macrophages) |
LPS 10ng/ml for 2 hours |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0050.2
|
IRF1 |
BMDM (bone marrow-derived macrophages) |
LPS 10ng/ml for 4 hours |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0050.2
|
IRF1 |
small intestine |
Prdm1/Blimp-1 mutant |
Permissive
Robust
|
Mus musculus |
GSE66069
...
|
MA0050.2
|
IRF1 |
BMDM (bone marrow-derived macrophages) |
no treatment |
Permissive
Robust
|
Mus musculus |
GSE77884
...
|
MA0050.2
|
IRF1 |
BMDM (bone marrow-derived macrophages) |
IFNg (400U/ml) 0.5h |
Permissive
Robust
|
Mus musculus |
GSE77884
...
|
MA0050.2
|
IRF1 |
BMDM (bone marrow-derived macrophages) |
IFNg (400U/ml) 3h |
Permissive
Robust
|
Mus musculus |
GSE77884
...
|
MA0050.2
|
IRF1 |
monocyte-derived macrophages |
FNA (25ng/ml) for 24 hours |
Permissive
|
Homo sapiens |
GSE100381
...
|
MA0050.2
|
IRF1 |
bone marrow-derived macrophages |
IFNg (100 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0050.2
|
IRF1 |
bone marrow-derived macrophages |
IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0050.2
|
IRF1 |
HAEC (human aortic endothelial cells) |
IL1b, 4h |
Permissive
Robust
|
Homo sapiens |
GSE89970
...
|
MA0050.2
|
IRF1 |
HAEC (human aortic endothelial cells) |
TNFa, 4h |
Permissive
Robust
|
Homo sapiens |
GSE89970
...
|
MA0050.2
|
IRF1 |
AT-3 (mammary tumor) |
DMSO vehicle |
Permissive
|
Mus musculus |
GSE94130
...
|
MA0050.2
|
IRF1 |
AT-3 (mammary tumor) |
1000nM JQ1 |
Permissive
|
Mus musculus |
GSE94130
...
|
MA0050.2
|
IRF1 |
AT-3 (mammary tumor) |
1ng/mL IFN-γ |
Permissive
Robust
|
Mus musculus |
GSE94130
...
|
MA0050.2
|
IRF1 |
AT-3 (mammary tumor) |
1000nM JQ1+ 1ng/mL IFN-γ |
Permissive
Robust
|
Mus musculus |
GSE94130
...
|
MA0050.2
|
IRF1 |
Th9-cells |
IFN-g |
Permissive
Robust
|
Mus musculus |
GSE96699
...
|
MA0050.2
|
IRF1 |
Th9-cells |
IFN-g |
Permissive
Robust
|
Mus musculus |
GSE96699
...
|
MA0050.2
|
IRF1 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 0h |
Permissive
Robust
|
Mus musculus |
GSE100962
...
|
MA0050.2
|
IRF1 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 1h |
Permissive
Robust
|
Mus musculus |
GSE100962
...
|
MA0050.2
|
IRF1 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 2h |
Permissive
Robust
|
Mus musculus |
GSE100962
...
|
MA0050.2
|
IRF1 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 6h |
Permissive
Robust
|
Mus musculus |
GSE100962
...
|
MA0050.2
|
IRF1 |
|
LPS |
Permissive
Robust
|
Homo sapiens |
GSE43036
|
MA0050.2
|
IRF1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0050.2
|
IRF1 |
small intestine |
|
Permissive
Robust
|
Mus musculus |
GSE66069
...
|
MA0050.2
|
IRF1 |
monocyte-derived macrophages |
|
Permissive
|
Homo sapiens |
GSE100381
...
|
MA0050.2
|
IRF1 |
bone marrow-derived macrophages |
|
Permissive
|
Mus musculus |
GSE84518
...
|
MA0050.2
|